50 MgMercaptopurine Tablets IP

Get a Price/Quote

MOQ : 1 Strip

50 MgMercaptopurine Tablets IP Specification

Dosage Form
Tablet

Salt Composition
Mercaptopurine 50 mg

Indication
Acute lymphocytic leukemia, chronic myeloid leukemia, and other certain types of cancers

Enzyme Types
Not an enzyme; antimetabolite cytotoxic medication

Feature
Film coated, easy to swallow, manufactured under GMP guidelines

Ingredients
Mercaptopurine and excipients

Application
Pharmaceutical, Oncology treatment

Physical Color/Texture
Pale yellow tablet, round and smooth

Fermentation Smell
Odorless

Storage Instructions
Store below 25C, protect from light and moisture, keep out of reach of children

Shelf Life
24-36 months from date of manufacture

About 50 MgMercaptopurine Tablets IP

Explore the rarefied world of oncology pharmaceuticals with 50 Mg Mercaptopurine Tablets IP, available at a special rate and competitive pricing. Polished with a classic film coating, these pale yellow, round tablets are easy to swallow and manufactured in WHO-GMP certified facilities, assuring top-tier quality standards. Each blister strip or bottle typically contains 10 tablets, formulated for oral administration in the treatment of acute lymphocytic leukemia and chronic myeloid leukemia. Prescription-only and odorless, these tablets must be used under strict medical supervision. Keep stock ready for dispatch-trusted by distributors, exporters, suppliers, and traders in India.

Features & Application of 50 Mg Mercaptopurine Tablets IP

The polished film-coated tablets are specially designed for ease of swallowing and reliable dosing. Used in the effective pharmaceutical management of certain cancers, especially acute lymphocytic and chronic myeloid leukemia, they act as classic antimetabolite cytotoxic medications. Manufactured under strict GMP guidelines, these tablets provide consistent quality and clinical performance for oncologists and healthcare professionals. Each tablet contains precisely 50 mg Mercaptopurine, along with selected excipients for optimal stability and absorption.

Export Market, Packaging & Logistics Details

Our goods transport process ensures timely packing and dispatch of 50 Mg Mercaptopurine Tablets IP to main export markets across Asia, Africa, and the Middle East. Packing details include blister strips or bottles, each strip having 10 tablets, stock ready for immediate shipment. Dispatch from the designated FOB port in India adheres to international standards, guaranteeing product integrity and prompt delivery to global clients.

FAQ's of 50 MgMercaptopurine Tablets IP:

Q: How should 50 Mg Mercaptopurine Tablets IP be stored to maintain their quality?

A: Store these tablets below 25C, protected from light and moisture, and keep them out of reach of children to preserve their effectiveness and shelf life.

Q: What is the main medical indication for using Mercaptopurine 50 mg tablets?

A: Mercaptopurine 50 mg tablets are primarily indicated for acute lymphocytic leukemia, chronic myeloid leukemia, and treatment of certain other cancers as an oncology therapeutic.

Q: When is a prescription required for Mercaptopurine tablets?

A: A valid medical prescription is always required. This medication should only be used under strict medical supervision due to its cytotoxic nature.

Q: Where are the 50 Mg Mercaptopurine Tablets IP manufactured?

A: These tablets are manufactured in WHO-GMP certified facilities in India, ensuring compliance with global pharmaceutical standards.

Q: What is the process for exporting 50 Mg Mercaptopurine Tablets IP internationally?

A: Export involves stock ready for dispatch, careful packing in blister strips or bottles, and transportation via the designated FOB port in India, following regulatory and quality guidelines.